Showing results (291-300 of 301) with videos related to

Sort By:
Pageof 31
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Nature Reviews. Rheumatology|January 7, 2021
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNETRosaria Talarico, Silvia Aguilera, Tobias Alexander, et al.
Arthritis Care & Research|August 29, 2023
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance RegistryJinoos Yazdany, Anna Ware, Zachary S Wallace, et al.
Rheumatology (Oxford, England)|December 6, 2017
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational StudySébastien Peytrignet, Christopher P Denton, Mark Lunt, et al.
Annals of the Rheumatic Diseases|February 12, 2017
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)Ariane L Herrick, Xiaoyan Pan, Sébastien Peytrignet, et al.
Clinical and Experimental Rheumatology|March 29, 2022
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNETRosaria Talarico, Silvia Aguilera, Tobias Alexander, et al.
The Lancet. Rheumatology|August 1, 2022
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational studyZara Izadi, Milena A Gianfrancesco, Gabriela Schmajuk, et al.
Annals of the Rheumatic Diseases|August 25, 2017
Mapping and predicting mortality from systemic sclerosisMuriel Elhai, Christophe Meune, Marouane Boubaya, et al.
Annals of the Rheumatic Diseases|January 8, 2018
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational StudyAriane L Herrick, Sebastien Peytrignet, Mark Lunt, et al.
The Lancet. Rheumatology|November 15, 2021
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort studySebastian E Sattui, Richard Conway, Michael S Putman, et al.
Pageof 31